LIN vs TERN
Linde plc Ordinary Shares (LIN) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the LIN and TERN stock pages for the full models.
Not investment advice.